CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 40 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q3 2016. The put-call ratio across all filers is 1.11 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $21,000 | -38.2% | 83,409 | +29.8% | 0.00% | – |
| Q1 2022 | $34,000 | -50.0% | 64,247 | -41.9% | 0.00% | – |
| Q4 2021 | $68,000 | +6.2% | 110,646 | +73.5% | 0.00% | – |
| Q3 2021 | $64,000 | -76.9% | 63,790 | -57.9% | 0.00% | – |
| Q2 2021 | $277,000 | -47.0% | 151,367 | -43.0% | 0.00% | – |
| Q1 2021 | $523,000 | +44.9% | 265,408 | -7.9% | 0.00% | – |
| Q4 2020 | $361,000 | -84.5% | 288,228 | -77.7% | 0.00% | -100.0% |
| Q3 2020 | $2,326,000 | +18.3% | 1,292,165 | +451.4% | 0.00% | 0.0% |
| Q2 2020 | $1,966,000 | +2388.6% | 234,322 | +1449.4% | 0.00% | – |
| Q1 2020 | $79,000 | -86.2% | 15,123 | -77.6% | 0.00% | -100.0% |
| Q4 2016 | $572,000 | +439.6% | 67,648 | +333.1% | 0.00% | +100.0% |
| Q3 2016 | $106,000 | – | 15,618 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 397,168 | $43,888 | 0.01% |
| CJM Wealth Advisers, Ltd. | 30,465 | $3,366 | 0.00% |
| Tekla Capital Management LLC | 154,310 | $17,051 | 0.00% |
| McAdam, LLC | 10,006 | $6 | 0.00% |
| Aries Wealth Management | 15,400 | $1,702 | 0.00% |
| WELLS FARGO & COMPANY/MN | 342,084 | $37,800 | 0.00% |
| JPMORGAN CHASE & CO | 43,415 | $5 | 0.00% |
| NORTHERN TRUST CORP | 207,329 | $22,910 | 0.00% |
| PINNACLE ASSOCIATES LTD | 18,580 | $2,053 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |